# EDGAR Filing Document

**Accession Number:** 0001815436
**File Stem:** 0001354457-25-000766
**Filing Date:** 2025-8
**Character Count:** 6314
**Document Hash:** 3e654434cb225fcf5c4ce586945871f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001354457-25-000766.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001354457-25-000766

**CONFORMED SUBMISSION TYPE**: 25-NSE

**CONFIRMING COPY**: 

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Advanced Health Intelligence Ltd
- **CENTRAL INDEX KEY:** 0001815436
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 25-NSE
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41089

**BUSINESS ADDRESS:**
- **STREET 1:** UNIT 5/71 - 73 THE ESPLANADE
- **CITY:** SOUTH PERTH
- **STATE:** C3
- **ZIP:** 6151
- **BUSINESS PHONE:** 61 8 9324 2099

**MAIL ADDRESS:**
- **STREET 1:** UNIT 5/71 - 73 THE ESPLANADE
- **CITY:** SOUTH PERTH
- **STATE:** C3
- **ZIP:** 6151

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advanced Human Imaging Ltd
- **DATE OF NAME CHANGE:** 20210625

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advanced Human Imaging, Inc.
- **DATE OF NAME CHANGE:** 20210513

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MyFiziq LTD
- **DATE OF NAME CHANGE:** 20200617
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nasdaq Stock Market LLC
- **CENTRAL INDEX KEY:** 0001354457

**ORGANIZATION NAME:**
- **EIN:** 521165937
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 25-NSE

**BUSINESS ADDRESS:**
- **STREET 1:** One Liberty Plaza
- **CITY:** New York
- **STATE:** NY
- **ZIP:** 10006
- **BUSINESS PHONE:** 301-978-4144

**MAIL ADDRESS:**
- **STREET 1:** Office of General Counsel
- **STREET 2:** 805 King Farm Blvd.
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** The Nasdaq Stock Market LLC
- **DATE OF NAME CHANGE:** 20060224

## Exhibit 99.25

```

Delisting Determination, The Nasdaq Stock Market, LLC, July 2, 2025,
Advanced Health Intelligence Ltd.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the security of Advanced Health Intelligence Ltd.
effective at the opening of the trading session on August 15, 2025.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(b).
The Company was notified of the Staff determination
on May 7, 2024.
On May 10, 2024 the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings Panel
(Panel) pursuant to Listing Rule 5815.
On June 20, 2024 the hearing was held. On June 8, 2024 the Panel
reached a decision and a Decision letter was
issued on June 9, 2024. On July 26, 2024 the Panel determined
to delist the security of the Company because the Company
failed to regain compliance as set forth in the Panel decision
Decision letter dated June 9, 2024.
On July 26, 2024, the Company was informed that it would be
suspended from the Exchange.
The Company security was suspended on July 30, 2024.
The Company appealed the suspension on August 8, 2024.
The Exchange reviewed the record in its entirety and affirmed the decision
of the Panel.  The Staff determination
to delist the Company security became final on March 19, 2025.

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 25

### NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

**Commission File Number:** 001-41089

|  |  |
|:---|:---|
| Issuer:                                                                                                             | Advanced Health Intelligence Ltd                          |
| Exchange:                                                                                                           | Nasdaq Stock Market LLC                                   |
| (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |  |
| Address:                                                                                                            | 71-73 South Perth Esplanade, South Perth, AUSTRALIA, 6151 |
| Telephone number:                                                                                                   | +61 449 655 966                                           |
| (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)   |  |
| (Description of class of securities)                                                                                | American Depositary Shares                                |

---

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

- [ ] 17 CFR 240.12d2-2(a)(1)
- [ ] 17 CFR 240.12d2-2(a)(2)
- [ ] 17 CFR 240.12d2-2(a)(3)
- [ ] 17 CFR 240.12d2-2(a)(4)
- [x] Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
- [ ] Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

---

Pursuant to the requirements of the Securities Exchange Act of 1934, Nasdaq Stock Market
LLC certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing the Form 25 and has caused this notification to be signed on its
behalf by the undersigned duly authorized person.

| Date       | By   | Name          | Title            |
|:---|:---|:---|:---|
| 2025-08-05 |  | Aravind Menon | Hearings Advisor |

Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR
240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.